Literature DB >> 7669562

Microsatellite instability in human prostate cancer.

M Watanabe1, H Imai, T Shiraishi, J Shimazaki, T Kotake, R Yatani.   

Abstract

Microsatellite instability (MSI) was examined at 36 loci, and found in 9 (43%) of the 21 prostatic cancers. A loss of heterozygosity had occurred in five cases (24%). MSI did not correlate with clinical stage, but might play a role in the development of a subset of prostate cancers.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7669562      PMCID： PMC2033912          DOI： 10.1038/bjc.1995.374

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  22 in total

1.  Construction of a GT polymorphism map of human 9q.

Authors:  D J Kwiatkowski; E P Henske; K Weimer; L Ozelius; J F Gusella; J Haines
Journal:  Genomics       Date:  1992-02       Impact factor: 5.736

2.  Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms.

Authors:  T J Hudson; M Engelstein; M K Lee; E C Ho; M J Rubenfield; C P Adams; D E Housman; N C Dracopoli
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

3.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

Authors:  D F Gleason; G T Mellinger
Journal:  J Urol       Date:  1974-01       Impact factor: 7.450

4.  Microsatellite instability in cancer of the proximal colon.

Authors:  S N Thibodeau; G Bren; D Schaid
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

5.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

6.  Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism.

Authors:  M H Jones; Y Nakamura
Journal:  Genes Chromosomes Cancer       Date:  1992-07       Impact factor: 5.006

7.  Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer.

Authors:  H J Han; A Yanagisawa; Y Kato; J G Park; Y Nakamura
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

8.  A novel primer extension method to detect the number of CAG repeats in the androgen receptor gene in families with X-linked spinal and bulbar muscular atrophy.

Authors:  Y Yamamoto; H Kawai; K Nakahara; M Osame; Y Nakatsuji; T Kishimoto; S Sakoda
Journal:  Biochem Biophys Res Commun       Date:  1992-01-31       Impact factor: 3.575

9.  Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.

Authors:  R Kikuchi-Yanoshita; M Konishi; S Ito; M Seki; K Tanaka; Y Maeda; H Iino; M Fukayama; M Koike; T Mori
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

10.  p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries.

Authors:  M Watanabe; T Ushijima; H Kakiuchi; T Shiraishi; R Yatani; J Shimazaki; T Kotake; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1994-09
View more
  4 in total

Review 1.  The application of microsatellites in molecular pathology.

Authors:  R Naidoo; R Chetty
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

2.  Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations.

Authors:  K V Honn; A Aref; Y Q Chen; M L Cher; J D Crissman; J D Forman; X Gao; D Grignon; M Hussain; A T Porter; J E Pontes; I Powell; B Redman; W Sakr; R Severson; D G Tang; D P Wood
Journal:  Pathol Oncol Res       Date:  1996-03       Impact factor: 3.201

3.  Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer.

Authors:  Colin C Pritchard; Colm Morrissey; Akash Kumar; Xiaotun Zhang; Christina Smith; Ilsa Coleman; Stephen J Salipante; Jennifer Milbank; Ming Yu; William M Grady; Jonathan F Tait; Eva Corey; Robert L Vessella; Tom Walsh; Jay Shendure; Peter S Nelson
Journal:  Nat Commun       Date:  2014-09-25       Impact factor: 14.919

4.  A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer.

Authors:  Inês Teles Alves; David Cano; René Böttcher; Hetty van der Korput; Winand Dinjens; Guido Jenster; Jan Trapman
Journal:  Oncotarget       Date:  2017-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.